The Upside Story Behind Concentra Group Holdings Parent, Inc. (CON)

Concentra Group Holdings Parent, Inc. (NYSE:CON) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Concentra Group Holdings Parent, Inc. (NYSE:CON) has a “Buy” or equivalent rating from all seven analysts covering the stock. While the target price ranges from $25 to $31, the median price target of $29 implies an upside potential of 48.95% from the current price.

After Concentra Group Holdings Parent, Inc. (NYSE:CON) announced its third-quarter results on November 6, several analysts reaffirmed their bullish outlook on the company. On November 10, Mizuho Securities maintained a Buy rating on the stock, with an unchanged price target of $28. Three days earlier, Joanna Gajuk, an analyst at Bank of America Securities, maintained a Buy rating on the company.

g-stockstudio/Shutterstock.com

In the third quarter, Concentra Group Holdings Parent, Inc. (NYSE:CON) reported increases in revenue, net income, and adjusted EBITDA of 17%, 8.9%, and 17.1%, respectively. Additionally, the company recorded a rise not only in revenue per visit but also in patient volumes.

As stated by Keith Newton, CEO of Concentra Group Holdings Parent, Inc. (NYSE:CON),

“Building on our business growth in the first half of the year, our strong third quarter results delivered year-over-year increases in revenue, net income, and Adjusted EBITDA driven by visit and rate growth, as well as executing on our inorganic strategy.”

Concentra Group Holdings Parent, Inc. (NYSE:CON), based in Addison, Texas, is a provider of occupational health services in the U.S. Founded in 1979, the company operates Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.